Thymic Peptide — T-Cell Modulation & Innate Immune Response
Thymosin Alpha-1 (Tα1) is a naturally occurring thymic peptide that modulates T-cell function and enhances innate immune responses. It is one of the few peptides with regulatory approval in multiple countries for immune support in chronic viral infections and as an immune adjunct.
Stimulates T-cell maturation and differentiation, enhances dendritic cell function, and modulates cytokine production. Supports both adaptive and innate immune pathways without overstimulating the immune system.
| Parameter | Details |
|---|---|
| Starting Dose | 500 mcg 2–3x/week |
| Moderate Dose | 1,000 mcg 2–3x/week |
| High Dose | 1,500 mcg 2–3x/week |
| Route | Subcutaneous injection |
| Immune Resilience | Notable within a few weeks |
Active Infection Warning
If the client has an active infection, dosing requires prescriber re-evaluation. Active infection changes the immune context and may alter how Tα1 modulates the response.
Clinical Note
Tα1 is one of the better-studied immune peptides with a favorable safety profile. Short cycles carry minimal risk in otherwise healthy individuals.
This guide is for educational and clinical-support purposes only. All dosing must be supervised by a licensed prescriber. Matrix Advanced Solutions does not provide medical advice. Always consult your healthcare provider before starting any peptide protocol.